1. Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878);Frei;Cancer Res,1969
2. Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer;Braakhuis;Cancer Res,1991
3. Review of phase I clinical studies with topotecan;Rowinsky;Semin Oncol,1997
4. Paclitaxel (taxol);Kohler;Pharmacotherapy,1994
5. Quinazoline antifolates: Dosage schedules and toxicity;Hutchison;Cancer Chemother Rep,1971